USA - NYSE:MD - US58502B1061 - Common Stock
The current stock price of MD is 17.44 USD. In the past month the price increased by 7.52%. In the past year, price increased by 14.66%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 13 | 104.57B | ||
| CI | THE CIGNA GROUP | 11.01 | 82.53B | ||
| LH | LABCORP HOLDINGS INC | 18.21 | 22.91B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 207.87 | 20.25B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.47 | 20.16B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.4 | 15.96B | ||
| HIMS | HIMS & HERS HEALTH INC | 60.29 | 10.90B | ||
| DVA | DAVITA INC | 13.37 | 9.26B | ||
| GH | GUARDANT HEALTH INC | N/A | 8.84B | ||
| CHE | CHEMED CORP | 19.53 | 6.36B | ||
| RDNT | RADNET INC | 226.75 | 6.28B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 61.51 | 5.99B |
Pediatrix Medical Group, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,150 full-time employees. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. The company offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. The company provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The firm provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
PEDIATRIX MEDICAL GROUP INC
1301 Concord Terrace
Sunrise FLORIDA 33323 US
CEO: Mark S. Ordan
Employees: 4120
Phone: 19543840175
Pediatrix Medical Group, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,150 full-time employees. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. The company offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. The company provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The firm provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
The current stock price of MD is 17.44 USD. The price decreased by -0.91% in the last trading session.
MD does not pay a dividend.
MD has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
PEDIATRIX MEDICAL GROUP INC (MD) operates in the Health Care sector and the Health Care Providers & Services industry.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MD.
PEDIATRIX MEDICAL GROUP INC (MD) will report earnings on 2025-11-03, before the market open.
ChartMill assigns a technical rating of 9 / 10 to MD. When comparing the yearly performance of all stocks, MD is one of the better performing stocks in the market, outperforming 84.6% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to MD. MD has only an average score on both its financial health and profitability.
Over the last trailing twelve months MD reported a non-GAAP Earnings per Share(EPS) of 1.81. The EPS increased by 53.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.66% | ||
| ROA | 5.23% | ||
| ROE | 13.18% | ||
| Debt/Equity | 0.7 |
15 analysts have analysed MD and the average price target is 16.92 USD. This implies a price decrease of -3.01% is expected in the next year compared to the current price of 17.44.
For the next year, analysts expect an EPS growth of 23.94% and a revenue growth -5.59% for MD